These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 20194710)
1. Adipokines and cardiometabolic profile in primary hyperaldosteronism. Iacobellis G; Petramala L; Cotesta D; Pergolini M; Zinnamosca L; Cianci R; De Toma G; Sciomer S; Letizia C J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710 [TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913 [TBL] [Abstract][Full Text] [Related]
3. Comparison of left ventricular structure and function in primary aldosteronism and essential hypertension by echocardiography. Yang Y; Zhu LM; Xu JZ; Tang XF; Gao PJ Hypertens Res; 2017 Mar; 40(3):243-250. PubMed ID: 27733767 [TBL] [Abstract][Full Text] [Related]
4. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447 [TBL] [Abstract][Full Text] [Related]
5. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003 [TBL] [Abstract][Full Text] [Related]
6. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Rossi GP; Sacchetto A; Pavan E; Palatini P; Graniero GR; Canali C; Pessina AC Circulation; 1997 Mar; 95(6):1471-8. PubMed ID: 9118515 [TBL] [Abstract][Full Text] [Related]
7. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. Turchi F; Ronconi V; di Tizio V; Ceccoli L; Boscaro M; Giacchetti G Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976 [TBL] [Abstract][Full Text] [Related]
8. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension]. Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950 [TBL] [Abstract][Full Text] [Related]
10. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis. Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD; J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781 [TBL] [Abstract][Full Text] [Related]
11. [Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension]. Deng YJ; Zhang SL; Liu PM; Mai LF; Tang JY; Yan L Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):743-749. PubMed ID: 27667270 [No Abstract] [Full Text] [Related]
12. Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension. Turchi F; Ronconi V; di Tizio V; Boscaro M; Giacchetti G Am J Hypertens; 2011 Dec; 24(12):1274-9. PubMed ID: 21850059 [TBL] [Abstract][Full Text] [Related]
13. Single dose captopril as a diagnostic test for primary aldosteronism. Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726 [TBL] [Abstract][Full Text] [Related]
14. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190 [TBL] [Abstract][Full Text] [Related]
16. Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study. Napoli C; Di Gregorio F; Leccese M; Abete P; Ambrosio G; Giusti R; Casini A; Ferrara N; De Matteis C; Sibilio G; Donzelli R; Montemarano A; Mazzeo C; Rengo F; Mansi L; Liguori A J Investig Med; 1999 May; 47(5):212-21. PubMed ID: 10361380 [TBL] [Abstract][Full Text] [Related]
17. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy. Kozłowska L; Rydzewski A; Fiderkiewicz B; Wasińska-Krawczyk A; Grzechnik A; Rosołowska-Huszcz D J Ren Nutr; 2010 Jul; 20(4):255-62. PubMed ID: 20537918 [TBL] [Abstract][Full Text] [Related]
18. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. Pilz S; Kienreich K; Drechsler C; Ritz E; Fahrleitner-Pammer A; Gaksch M; Meinitzer A; März W; Pieber TR; Tomaschitz A J Clin Endocrinol Metab; 2012 Jan; 97(1):E75-9. PubMed ID: 22013107 [TBL] [Abstract][Full Text] [Related]
19. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. Lin YH; Wang SM; Wu VC; Lee JK; Kuo CC; Yen RF; Liu KL; Huang KH; Chueh SC; Wang WJ; Lin LY; Chien KL; Ho YL; Chen MF; Wu KD; Eur J Clin Invest; 2011 Jul; 41(7):743-50. PubMed ID: 21250985 [TBL] [Abstract][Full Text] [Related]
20. Myocardial ultrasound tissue characterization of patients with primary aldosteronism. Lee HH; Hung CS; Wu XM; Wu VC; Liu KL; Wang SM; Lin LC; Chen PC; Guo YL; Chueh SC; Lin YH; Ho YL; Wu KD; Ultrasound Med Biol; 2013 Jan; 39(1):54-61. PubMed ID: 23200178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]